the wisdom to heal

The expertise to transform the way challenging diseases and conditions are treated

Noveome is a clinical-stage biopharmaceutical company advancing ST266— a first-of-its-kind, multi-targeted secretome containing hundreds of biologically active proteins and other factors crucial to neuroprotection, the modulation of inflammation, cell recovery and healing.

ST266 contains physiologic levels of hundreds of active biomolecules, including growth factors and cytokines. These molecules modulate a host of biological pathways, including anti-inflammatory and neuroprotective mechanisms, critical to healing. Learn more about the science behind ST266 >

In both preclinical and clinical studies, ST266 has been shown to be well-tolerated with demonstrated biologic activity. We believe it holds significant promise to improve clinical outcomes in a range of complex diseases and conditions in categories as diverse as ophthalmology, neurology, dermatology and more. Explore our advancing pipeline >


Our experienced management team has an established track record of advancing promising drug candidates from discovery through development and commercialization.

Patrick T. Welch

Interim CEO/Board Member


Larry R. Brown, Sc.D.

Research & Development Executive Vice President/Chief Scientific Officer


board of directors

We are advised by an independent Board of Directors that includes experts in healthcare technology, intellectual property, investment and management.

Ronald K. Poropatich M.D., M.S.

Board Member/Interim Chairman of the Board


Eric Keller, J.D.

Board Member


Houman Hemmati, M.D., Ph.D.

Board Member


Robert S. Langer, Sc.D.

Board Member


Patrick T. Welch

Board Member/Interim CEO


contact us

Noveome received seed funding and access to world-class researchers, physicians and experts in private and public reimbursement at Pittsburgh ‘s leading healthcare institutions, including UPMC Health System, Highmark Blue Cross/Blue Shield, the University of Pittsburgh and Carnegie Mellon University. We are passionate about helping the Pittsburgh region grow into the world’s next great nexus for biotechnology.

Corporate Headquarters
100 Technology Drive, Suite 200
Pittsburgh, PA 15219

Call us at: +1.412.402.9914

General inquiries
Please contact us at:

Clinical inquiries
Please contact us at:

For urgent clinical inquiries,
please contact your treating physician
or clinical study investigator.

Healthcare Professionals
Please contact us at:

Investor Inquiries
Please contact:

Current Investors:

For Investment Opportunities: